One year and a half after ChatGPT blew away all preconceived notions of where tech was headed, generative AI continues to command executive-level excitement and investment mandates, even among companies that don’t have a clear GenAI strategy.and continue piling on to the tune of $151 billion in 2027. But while some companies are investing in GenAI to lead, and others are doing it to avoid being the caboose, many are putting their money on GenAI simply because it’s the thing to do.
While today’s GenAI was just launched over a year ago, these regulated, AI-forward companies bring informed, holistic perspectives on GenAI molded by decades of successfully deploying “traditional” AI to transform their businesses. Unlike many of the organizations whose enthusiasm helps sustain GenAI’s inflated mystique, the true pioneers of AI never saw GenAI as a corporate panacea.
GenAI truly is a transformative tool, but it should be used to elevate an organization’s AI capabilities, not replace them. GenAI exists to serve the use cases that benefit most from what it can do. It works best as part of an integrated mix of AI technologies tailored for specific needs and data contexts.